Prospective Registry Study of Endovascular Treatment for Acute Ischemic Stroke Patients
Study Details
Study Description
Brief Summary
To investigate the real situation of assessment, diagnosis and treatment of acute ischemic stroke patients with endovascular therapy.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
|
Detailed Description
Prospective Registry Study of Endovascular Treatment for Acute Ischemic Stroke Patients is an academic,independent, pragmatic , prospective, multicenter, observational registry study. The acute ischemic stroke patients undergone endovascular therapy will be enrolled in stroke centers. Baseline information and clinical follow-up information at 90 days of stroke onset are collected. Data collected include demographics, comorbidities, pathogenesis, blood pressures, stroke severity on admission, time intervals, reperfusion condition, and functional outcome, et al. The study aims to investigate the real situation of assessment, diagnosis and treatment of acute ischemic stroke patients with endovascular therapy.
Study Design
Outcome Measures
Primary Outcome Measures
- The modified Rankin Scale score at 90 days [90 days]
The range of the modified Rankin Scale is from 0 to 6. A higher score indicates a worse outcome. 0-No symptoms; 1-No significant disability; 2-Slight disability; 3-Moderate disability; 4-Moderately severe disability; 5-Severe disability; 6-Dead.
Secondary Outcome Measures
- Successful reperfusion rate [90 days]
- symptomatic intracranial hemorrhage or death within 90 days after stroke onset. [90 days]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Acute ischemic stroke;
-
Brain imaging confirmed intracranial large vessel occlusion: intracranial internal carotid artery (ICA), middle cerebral artery (MCA M1/M2), anterior cerebral artery (ACA A1/A2), basilar artery (BA), vertebral artery (VA V4), and posterior cerebral artery (PCA P1);
-
Initiation of any type of endovascular treatment, including mechanical thrombectomy, aspiration, angioplasty, and stenting;
-
Informed Consent as documented by signature or fulfilling the criteria for emergency consent/ deferral consent
Exclusion Criteria:
-
Acute intracranial haemorrhage
-
No evidence of large vessel occlusion on digital subtraction angiography.
-
Patient bedridden or presenting from a nursing home
-
Foreseeable difficulties in follow-up due to geographic reasons (e.g. patients living abroad) -
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Zhangzhou Municipal Hospital | Zhangzhou | Fujian | China | 36300 |
| 2 | Gansu provincial hospital of TCM | Lanzhou | Gansu | China | 730050 |
| 3 | Jiamusi Central Hospital | Jiamusi | Heilongjiang | China | 154000 |
| 4 | Department of Neurology, The First Affiliated Hospital of Nanchang University | Nanchang | Jiangxi | China | 330006 |
| 5 | Songyuan Jilin Oilfield Hospital | SongYuan | Jilin | China | 138000 |
| 6 | Shenyang First People's Hospital | Shenyang | Liaoning | China | 110091 |
Sponsors and Collaborators
- Wen-huo Chen
Investigators
- Principal Investigator: Wen-huo Chen, bachelor, Zhangzhou Affiliated Hospital to Fujian Medical University , Fujian ,China
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- ETERNITY